Apyx Medical
APYX
67 hedge funds and large institutions have $95.6M invested in Apyx Medical in 2026 Q2 according to their latest regulatory filings, with 10 funds opening new positions, 22 increasing their positions, 23 reducing their positions, and 10 closing their positions.
35% more capital inflows, than outflows
Capital inflows: $7.68M | Capital outflows: $5.67M
1.12% more ownership
Funds ownership: 49.75% → 50.87% (+1.1%)
0% more funds holding
Funds holding: 67 → 67 (0)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
0% more first-time investments, than exits
New positions opened: 10 | Existing positions closed: 10
4% less repeat investments, than reductions
Existing positions increased: 22 | Existing positions reduced: 23
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RA
Royce & Associates
New York
|
+$2.63M |
| 2 |
Renaissance Technologies
New York
|
+$999K |
| 3 |
EIM
Essex Investment Management
Boston,
Massachusetts
|
+$933K |
| 4 |
Marshall Wace
London,
United Kingdom
|
+$692K |
| 5 |
LCM
Legato Capital Management
San Francisco,
California
|
+$404K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SEI Investments
Oaks,
Pennsylvania
|
-$1.26M |
| 2 |
UBS Group
Zurich,
Switzerland
|
-$867K |
| 3 |
NCM
Nantahala Capital Management
New Canaan,
Connecticut
|
-$674K |
| 4 |
ACM
Archon Capital Management
Seattle,
Washington
|
-$580K |
| 5 |
EI
EAM Investors
Solana Beach,
California
|
-$301K |
APYX Hedge Fund Activity: Q2 2026 in Review
67 of the 8,352 institutional investors tracked by Wall St. Rank reported a position in Apyx Medical (APYX) for Q2 2026, worth a combined $95.6M — up 25% from $76.8M a quarter earlier.
Fund positioning in APYX was balanced in Q2 2026: 10 funds opened new positions, 10 closed out, 22 added to existing stakes and 23 trimmed.
The largest buyer was Royce & Associates, adding an estimated $2.63M. The largest seller was SEI Investments, cutting an estimated $1.26M.
- 67 institutional investors held Apyx Medical (APYX) as of Q2 2026, unchanged from Q1 2026.
- Funds reported $95.6M of Apyx Medical stock for Q2 2026, up 25% quarter-over-quarter.
- 10 funds opened new Apyx Medical positions in Q2 2026 and 10 closed out, a net change of 0 holders.
- The largest Apyx Medical buyer in Q2 2026 was Royce & Associates, an estimated $2.63M added.
- The largest Apyx Medical seller in Q2 2026 was SEI Investments, an estimated $1.26M sold.
Based on aggregated 13F filings for Q2 2026.